TGF-β1/Smad3 Signaling Pathway Mediates T-2 Toxin-Induced Decrease of Type II Collagen in Cultured Rat Chondrocytes

Area of Science:

• Biochemistry
• Cell Biology
• Toxicology

Background:

• T-2 toxin is known to cause articular cartilage damage.
• The precise molecular mechanisms underlying T-2 toxin-induced chondrocyte damage are not fully understood.

Purpose of the Study:

• To investigate the role of the transforming growth factor-beta 1 (TGF-β1)/Smad3 signaling pathway in T-2 toxin-induced chondrocyte damage.
• To elucidate the molecular mechanisms of T-2 toxin's effects on articular cartilage.

Main Methods:

• Primary rat chondrocytes were cultured and treated with T-2 toxin.
• Cell viability and apoptosis were assessed.
• Levels of type II collagen, TGF-β1, Smad3, ALK5, and matrix metalloproteinase 13 (MMP13) were measured at mRNA and protein levels.
• Inhibitors of TGF-β1 and Smad3 were used to explore pathway involvement.

Main Results:

• T-2 toxin reduced chondrocyte viability and increased apoptosis.
• T-2 toxin decreased type II collagen production while upregulating TGF-β1, Smad3, ALK5, and MMP13.
• Increased phosphorylation of Smad3 (P-Smad3) was observed.
• TGF-β1 and Smad3 inhibitors partially reversed T-2 toxin's effects.
• T-2 toxin promotes MMP13 via TGF-β1 signaling, leading to collagen II downregulation and chondrocyte damage.

Conclusions:

• The TGF-β1/Smad3 signaling pathway is implicated in T-2 toxin-induced chondrocyte damage.
• T-2 toxin-induced MMP13 upregulation contributes to type II collagen reduction and chondrocyte injury.
• Smad3 may play a role in type II collagen degradation, independent of MMP13 regulation.